Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for 3-(1-Piperazinyl)-1,2-benzisothiazole was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on 3-(1-Piperazinyl)-1,2-benzisothiazole cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The North American market for 3-(1-Piperazinyl)-1,2-benzisothiazole was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for 3-(1-Piperazinyl)-1,2-benzisothiazole was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for 3-(1-Piperazinyl)-1,2-benzisothiazole was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the 3-(1-Piperazinyl)-1,2-benzisothiazole market include Ontario Chemicals, Inc, CNH Technologies, Inc., VGS Synthesis, Vihita Chem, Integrin Life Sciences, Sintilla Medcoms, PSN Medicare, Lakshmi Farmachem, Jinan Jianfeng Chemical, Xi'an Yutebang Pharmaceutical Technology, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for 3-(1-Piperazinyl)-1,2-benzisothiazole, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The 3-(1-Piperazinyl)-1,2-benzisothiazole market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding 3-(1-Piperazinyl)-1,2-benzisothiazole.
Market Segmentation
Report Metric
Details
Report Title
3-(1-Piperazinyl)-1,2-benzisothiazole- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Market Size Available for Years
2026-2032
Global 3-(1-Piperazinyl)-1,2-benzisothiazole Companies Covered
Ontario Chemicals, Inc
CNH Technologies, Inc.
VGS Synthesis
Vihita Chem
Integrin Life Sciences
Sintilla Medcoms
PSN Medicare
Lakshmi Farmachem
Jinan Jianfeng Chemical
Xi'an Yutebang Pharmaceutical Technology
Shanghai Sunwise Chemical
Jinan Aery Pharmaceutical
Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market, Segment by Type
Purity 99%
Purity 98.5%
Purity 98%
Others
Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market, Segment by Application
Organic Synthesis Intermediates
Pharmaceutical Intermediates
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the 3-(1-Piperazinyl)-1,2-benzisothiazole manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents 3-(1-Piperazinyl)-1,2-benzisothiazole sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents 3-(1-Piperazinyl)-1,2-benzisothiazole sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 3-(1-Piperazinyl)-1,2-benzisothiazole Product Introduction
1.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size Forecast
1.2.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (2021–2032)
1.2.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume (2021–2032)
1.2.3 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Price (2021–2032)
1.3 3-(1-Piperazinyl)-1,2-benzisothiazole Market Trends & Drivers
1.3.1 3-(1-Piperazinyl)-1,2-benzisothiazole Industry Trends
1.3.2 3-(1-Piperazinyl)-1,2-benzisothiazole Market Drivers & Opportunities
1.3.3 3-(1-Piperazinyl)-1,2-benzisothiazole Market Challenges
1.3.4 3-(1-Piperazinyl)-1,2-benzisothiazole Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Players Revenue Ranking (2025)
2.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue by Company (2021–2026)
2.3 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume Ranking of Players (2025)
2.4 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Company (2021–2026)
2.5 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Average Price by Company (2021–2026)
2.6 Key Manufacturers 3-(1-Piperazinyl)-1,2-benzisothiazole Manufacturing Base and Headquarters
2.7 Key Manufacturers 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
2.8 Key Manufacturers Start of Mass Production of 3-(1-Piperazinyl)-1,2-benzisothiazole
2.9 3-(1-Piperazinyl)-1,2-benzisothiazole Market Competitive Analysis
2.9.1 3-(1-Piperazinyl)-1,2-benzisothiazole Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on 3-(1-Piperazinyl)-1,2-benzisothiazole revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation 3-(1-Piperazinyl)-1,2-benzisothiazole Market Classification
3.1 Introduction by Type
3.1.1 Purity 99%
3.1.2 Purity 98.5%
3.1.3 Purity 98%
3.1.4 Others
3.1.5 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type
3.1.5.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, by Type (2021–2032)
3.1.5.3 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, by Type (%), 2021–2032
3.1.6 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Type
3.1.6.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume, by Type (2021–2032)
3.1.6.3 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume, by Type (%), 2021–2032
3.1.7 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Organic Synthesis Intermediates
4.1.2 Pharmaceutical Intermediates
4.1.3 Others
4.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application
4.2.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, by Application (2021–2032)
4.2.3 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, by Application (%), 2021–2032
4.3 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Application
4.3.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume, by Application (2021–2032)
4.3.3 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume, by Application (%), 2021–2032
4.4 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region
5.1.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region (2021–2026)
5.1.3 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region (2027–2032)
5.1.4 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region (%), 2021–2032
5.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Region
5.2.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Region (2021–2026)
5.2.3 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Region (2027–2032)
5.2.4 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Region (%), 2021–2032
5.3 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
5.4.2 North America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
5.5.2 Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
5.6.2 Asia Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
5.7.2 South America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
5.8.2 Middle East & Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value and Sales Volume
6.2.1 Key Countries/Regions 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
6.2.2 Key Countries/Regions 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume, 2021–2032
6.3 United States
6.3.1 United States 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
6.3.2 United States 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
6.3.3 United States 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
6.4.2 Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
6.5.2 China 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
6.5.3 China 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
6.6.2 Japan 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
6.7.2 South Korea 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
6.8.2 Southeast Asia 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021–2032
6.9.2 India 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
6.9.3 India 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Ontario Chemicals, Inc
7.1.1 Ontario Chemicals, Inc Company Information
7.1.2 Ontario Chemicals, Inc Introduction and Business Overview
7.1.3 Ontario Chemicals, Inc 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Ontario Chemicals, Inc 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.1.5 Ontario Chemicals, Inc Recent Developments
7.2 CNH Technologies, Inc.
7.2.1 CNH Technologies, Inc. Company Information
7.2.2 CNH Technologies, Inc. Introduction and Business Overview
7.2.3 CNH Technologies, Inc. 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 CNH Technologies, Inc. 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.2.5 CNH Technologies, Inc. Recent Developments
7.3 VGS Synthesis
7.3.1 VGS Synthesis Company Information
7.3.2 VGS Synthesis Introduction and Business Overview
7.3.3 VGS Synthesis 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 VGS Synthesis 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.3.5 VGS Synthesis Recent Developments
7.4 Vihita Chem
7.4.1 Vihita Chem Company Information
7.4.2 Vihita Chem Introduction and Business Overview
7.4.3 Vihita Chem 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Vihita Chem 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.4.5 Vihita Chem Recent Developments
7.5 Integrin Life Sciences
7.5.1 Integrin Life Sciences Company Information
7.5.2 Integrin Life Sciences Introduction and Business Overview
7.5.3 Integrin Life Sciences 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Integrin Life Sciences 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.5.5 Integrin Life Sciences Recent Developments
7.6 Sintilla Medcoms
7.6.1 Sintilla Medcoms Company Information
7.6.2 Sintilla Medcoms Introduction and Business Overview
7.6.3 Sintilla Medcoms 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Sintilla Medcoms 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.6.5 Sintilla Medcoms Recent Developments
7.7 PSN Medicare
7.7.1 PSN Medicare Company Information
7.7.2 PSN Medicare Introduction and Business Overview
7.7.3 PSN Medicare 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 PSN Medicare 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.7.5 PSN Medicare Recent Developments
7.8 Lakshmi Farmachem
7.8.1 Lakshmi Farmachem Company Information
7.8.2 Lakshmi Farmachem Introduction and Business Overview
7.8.3 Lakshmi Farmachem 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Lakshmi Farmachem 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.8.5 Lakshmi Farmachem Recent Developments
7.9 Jinan Jianfeng Chemical
7.9.1 Jinan Jianfeng Chemical Company Information
7.9.2 Jinan Jianfeng Chemical Introduction and Business Overview
7.9.3 Jinan Jianfeng Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Jinan Jianfeng Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.9.5 Jinan Jianfeng Chemical Recent Developments
7.10 Xi'an Yutebang Pharmaceutical Technology
7.10.1 Xi'an Yutebang Pharmaceutical Technology Company Information
7.10.2 Xi'an Yutebang Pharmaceutical Technology Introduction and Business Overview
7.10.3 Xi'an Yutebang Pharmaceutical Technology 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Xi'an Yutebang Pharmaceutical Technology 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.10.5 Xi'an Yutebang Pharmaceutical Technology Recent Developments
7.11 Shanghai Sunwise Chemical
7.11.1 Shanghai Sunwise Chemical Company Information
7.11.2 Shanghai Sunwise Chemical Introduction and Business Overview
7.11.3 Shanghai Sunwise Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Shanghai Sunwise Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.11.5 Shanghai Sunwise Chemical Recent Developments
7.12 Jinan Aery Pharmaceutical
7.12.1 Jinan Aery Pharmaceutical Company Information
7.12.2 Jinan Aery Pharmaceutical Introduction and Business Overview
7.12.3 Jinan Aery Pharmaceutical 3-(1-Piperazinyl)-1,2-benzisothiazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Jinan Aery Pharmaceutical 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
7.12.5 Jinan Aery Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 3-(1-Piperazinyl)-1,2-benzisothiazole Industrial Chain
8.2 3-(1-Piperazinyl)-1,2-benzisothiazole Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Model
8.5.2 Sales Channels
8.5.3 3-(1-Piperazinyl)-1,2-benzisothiazole Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. 3-(1-Piperazinyl)-1,2-benzisothiazole Market Trends
Table 2. 3-(1-Piperazinyl)-1,2-benzisothiazole Market Drivers & Opportunities
Table 3. 3-(1-Piperazinyl)-1,2-benzisothiazole Market Challenges
Table 4. 3-(1-Piperazinyl)-1,2-benzisothiazole Market Restraints
Table 5. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue by Company (US$ Million), 2021–2026
Table 6. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue Market Share by Company (2021–2026)
Table 7. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Company (Tons), 2021–2026
Table 8. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market 3-(1-Piperazinyl)-1,2-benzisothiazole Price by Company (US$/Ton), 2021–2026
Table 10. Key Manufacturers 3-(1-Piperazinyl)-1,2-benzisothiazole Manufacturing Base and Headquarters
Table 11. Key Manufacturers 3-(1-Piperazinyl)-1,2-benzisothiazole Product Type
Table 12. Key Manufacturers Start of Mass Production of 3-(1-Piperazinyl)-1,2-benzisothiazole
Table 13. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on 3-(1-Piperazinyl)-1,2-benzisothiazole revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (US$ Million), 2021–2026
Table 18. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (US$ Million), 2027–2032
Table 19. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Share in Value by Type (2021–2026)
Table 20. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Share in Value by Type (2027–2032)
Table 21. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Type: 2021 vs 2025 vs 2032 (Tons)
Table 22. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Type (Tons), 2021–2026
Table 23. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Type (Tons), 2027–2032
Table 24. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Share in Volume by Type (2021–2026)
Table 25. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Share in Volume by Type (2027–2032)
Table 26. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Price by Type (US$/Ton), 2021–2026
Table 27. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Price by Type (US$/Ton), 2027–2032
Table 28. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application (US$ Million), 2021–2026
Table 30. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application (US$ Million), 2027–2032
Table 31. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Share in Value by Application (2021–2026)
Table 32. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Share in Value by Application (2027–2032)
Table 33. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons)
Table 34. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Application (Tons), 2021–2026
Table 35. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Application (Tons), 2027–2032
Table 36. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Share in Volume by Application (2021–2026)
Table 37. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Share in Volume by Application (2027–2032)
Table 38. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Price by Application (US$/Ton), 2021–2026
Table 39. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Price by Application (US$/Ton), 2027–2032
Table 40. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region (US$ Million), 2021–2026
Table 42. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region (US$ Million), 2027–2032
Table 43. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region (%), 2021–2026
Table 44. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region (%), 2027–2032
Table 45. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Region (Tons): 2021 vs 2025 vs 2032
Table 46. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Region (Tons), 2021–2026
Table 47. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Region (Tons), 2027–2032
Table 48. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Region (%), 2021–2026
Table 49. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Region (%), 2027–2032
Table 50. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Average Price by Region (US$/Ton), 2021–2026
Table 51. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Average Price by Region (US$/Ton), 2027–2032
Table 52. Key Countries/Regions 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume, (Tons), 2021–2026
Table 56. Key Countries/Regions 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume, (Tons), 2027–2032
Table 57. Ontario Chemicals, Inc Company Information
Table 58. Ontario Chemicals, Inc Introduction and Business Overview
Table 59. Ontario Chemicals, Inc 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 60. Ontario Chemicals, Inc 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 61. Ontario Chemicals, Inc Recent Developments
Table 62. CNH Technologies, Inc. Company Information
Table 63. CNH Technologies, Inc. Introduction and Business Overview
Table 64. CNH Technologies, Inc. 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 65. CNH Technologies, Inc. 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 66. CNH Technologies, Inc. Recent Developments
Table 67. VGS Synthesis Company Information
Table 68. VGS Synthesis Introduction and Business Overview
Table 69. VGS Synthesis 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 70. VGS Synthesis 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 71. VGS Synthesis Recent Developments
Table 72. Vihita Chem Company Information
Table 73. Vihita Chem Introduction and Business Overview
Table 74. Vihita Chem 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 75. Vihita Chem 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 76. Vihita Chem Recent Developments
Table 77. Integrin Life Sciences Company Information
Table 78. Integrin Life Sciences Introduction and Business Overview
Table 79. Integrin Life Sciences 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 80. Integrin Life Sciences 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 81. Integrin Life Sciences Recent Developments
Table 82. Sintilla Medcoms Company Information
Table 83. Sintilla Medcoms Introduction and Business Overview
Table 84. Sintilla Medcoms 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 85. Sintilla Medcoms 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 86. Sintilla Medcoms Recent Developments
Table 87. PSN Medicare Company Information
Table 88. PSN Medicare Introduction and Business Overview
Table 89. PSN Medicare 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 90. PSN Medicare 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 91. PSN Medicare Recent Developments
Table 92. Lakshmi Farmachem Company Information
Table 93. Lakshmi Farmachem Introduction and Business Overview
Table 94. Lakshmi Farmachem 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 95. Lakshmi Farmachem 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 96. Lakshmi Farmachem Recent Developments
Table 97. Jinan Jianfeng Chemical Company Information
Table 98. Jinan Jianfeng Chemical Introduction and Business Overview
Table 99. Jinan Jianfeng Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 100. Jinan Jianfeng Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 101. Jinan Jianfeng Chemical Recent Developments
Table 102. Xi'an Yutebang Pharmaceutical Technology Company Information
Table 103. Xi'an Yutebang Pharmaceutical Technology Introduction and Business Overview
Table 104. Xi'an Yutebang Pharmaceutical Technology 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 105. Xi'an Yutebang Pharmaceutical Technology 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 106. Xi'an Yutebang Pharmaceutical Technology Recent Developments
Table 107. Shanghai Sunwise Chemical Company Information
Table 108. Shanghai Sunwise Chemical Introduction and Business Overview
Table 109. Shanghai Sunwise Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 110. Shanghai Sunwise Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 111. Shanghai Sunwise Chemical Recent Developments
Table 112. Jinan Aery Pharmaceutical Company Information
Table 113. Jinan Aery Pharmaceutical Introduction and Business Overview
Table 114. Jinan Aery Pharmaceutical 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 115. Jinan Aery Pharmaceutical 3-(1-Piperazinyl)-1,2-benzisothiazole Product Offerings
Table 116. Jinan Aery Pharmaceutical Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Key Suppliers of Raw Materials Lists
Table 119. 3-(1-Piperazinyl)-1,2-benzisothiazole Downstream Customers
Table 120. 3-(1-Piperazinyl)-1,2-benzisothiazole Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. 3-(1-Piperazinyl)-1,2-benzisothiazole Product Picture
Figure 2. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 4. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume (Tons), 2021–2032
Figure 5. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Price (US$/Ton), 2021–2032
Figure 6. 3-(1-Piperazinyl)-1,2-benzisothiazole Report Years Considered
Figure 7. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Players Revenue Ranking (US$ Million), 2025
Figure 8. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume Ranking of Players (Tons), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue in 2025
Figure 10. 3-(1-Piperazinyl)-1,2-benzisothiazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Purity 99% Picture
Figure 12. Purity 98.5% Picture
Figure 13. Purity 98% Picture
Figure 14. Others Picture
Figure 15. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value Market Share by Type, 2025 & 2032
Figure 17. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Type (Tons), 2021 vs 2025 vs 2032
Figure 18. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume Market Share by Type, 2025 & 2032
Figure 19. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Price by Type (US$/Ton), 2021–2032
Figure 20. Product Picture of Organic Synthesis Intermediates
Figure 21. Product Picture of Pharmaceutical Intermediates
Figure 22. Product Picture of Others
Figure 23. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value Market Share by Application, 2025 & 2032
Figure 25. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Application (Tons), 2021 vs 2025 vs 2032
Figure 26. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume Market Share by Application, 2025 & 2032
Figure 27. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Price by Application (US$/Ton), 2021–2032
Figure 28. North America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 29. North America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Country (%), 2025 vs 2032
Figure 30. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 31. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Country (%), 2025 vs 2032
Figure 32. Asia Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 33. Asia Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Region (%), 2025 vs 2032
Figure 34. South America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 35. South America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Country (%), 2025 vs 2032
Figure 36. Middle East & Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 37. Middle East & Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Country (%), 2025 vs 2032
Figure 38. Key Countries/Regions 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (%), 2021–2032
Figure 39. Key Countries/Regions 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume (%), 2021–2032
Figure 40. United States 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 41. United States 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
Figure 42. United States 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application (%), 2025 vs 2032
Figure 43. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 44. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
Figure 45. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application (%), 2025 vs 2032
Figure 46. China 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 47. China 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
Figure 48. China 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application (%), 2025 vs 2032
Figure 49. Japan 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 50. Japan 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
Figure 51. Japan 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application (%), 2025 vs 2032
Figure 52. South Korea 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 53. South Korea 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
Figure 54. South Korea 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application (%), 2025 vs 2032
Figure 55. Southeast Asia 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 56. Southeast Asia 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
Figure 57. Southeast Asia 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application (%), 2025 vs 2032
Figure 58. India 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value (US$ Million), 2021–2032
Figure 59. India 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Type (%), 2025 vs 2032
Figure 60. India 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Value by Application (%), 2025 vs 2032
Figure 61. 3-(1-Piperazinyl)-1,2-benzisothiazole Industrial Chain
Figure 62. 3-(1-Piperazinyl)-1,2-benzisothiazole Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives InterviewedDescription
The global market for 3-(1-Piperazinyl)-1,2-benzisothiazole was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on 3-(1-Piperazinyl)-1,2-benzisothiazole cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The North American market for 3-(1-Piperazinyl)-1,2-benzisothiazole was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for 3-(1-Piperazinyl)-1,2-benzisothiazole was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for 3-(1-Piperazinyl)-1,2-benzisothiazole was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the 3-(1-Piperazinyl)-1,2-benzisothiazole market include Ontario Chemicals, Inc, CNH Technologies, Inc., VGS Synthesis, Vihita Chem, Integrin Life Sciences, Sintilla Medcoms, PSN Medicare, Lakshmi Farmachem, Jinan Jianfeng Chemical, Xi'an Yutebang Pharmaceutical Technology, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for 3-(1-Piperazinyl)-1,2-benzisothiazole, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The 3-(1-Piperazinyl)-1,2-benzisothiazole market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding 3-(1-Piperazinyl)-1,2-benzisothiazole.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the 3-(1-Piperazinyl)-1,2-benzisothiazole manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents 3-(1-Piperazinyl)-1,2-benzisothiazole sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents 3-(1-Piperazinyl)-1,2-benzisothiazole sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Related Reports
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-06-11
Pages: 170
USD 4900.00
(Single User License)
The global 3-(1-Piperazinyl)-1,2-benzisothiazole revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-06-11
Pages: 124
USD 4350.00
(Single User License)
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-06-11
Pages: 104
USD 2900.00
(Single User License)
The global market for 3-(1-Piperazinyl)-1,2-benzisothiazole was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 126
USD 3950.00
(Single User License)
The global market for 3-(1-Piperazinyl)-1,2-benzisothiazole was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 99
USD 4250.00
(Single User License)
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 168
USD 4900.00
(Single User License)
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 136
USD 2900.00
(Single User License)
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 93
USD 4250.00
(Single User License)
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 154
USD 4900.00
(Single User License)
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-06-11
Pages: 170
The global 3-(1-Piperazinyl)-1,2-benzisothiazole revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-06-11
Pages: 124
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-06-11
Pages: 104
The global market for 3-(1-Piperazinyl)-1,2-benzisothiazole was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 126
The global market for 3-(1-Piperazinyl)-1,2-benzisothiazole was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 96
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 99
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 168
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 136
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 93
The global 3-(1-Piperazinyl)-1,2-benzisothiazole market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 154
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database